2nd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT New —
KARIN HOELZER —
HEIDI ROSS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Rare Disease Initiatives. Newborn Screening. Step Therapy.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT New —
ALLISON HERRITY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Inflation Reduction Act Implementation.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT New —
KARIN HOELZER —
HEIDI ROSS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.

LobbyistCovered position, as disclosed
KARIN HOELZER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.